Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-023-01482-9, published online 22 May 2023
In our recent review of the article [1], the author noticed that the dots (red squares) in Fig 1m were accidentally removed from its original location during figure formatting, and the related data analysis is correct. Furthermore, we checked this paper again and this situation only occurred in Fig 1m. In addition, in Fig 1c, a legend for SARS-CoV-1 is missing and we have supplemented it. For the text section, no modifications are required. The correct data are provided as follows. The key findings of the article are not affected by these corrections. The original article has been corrected. We regret any inconvenience this has caused.
-
(1)
In Fig 1c, a legend for SARS-CoV-1 is missing. The correct image is as below.
Fig 1c Compound JZD-07 is a potent inhibitor of SARS-CoV-2 3CLpro as well as SARS-CoV-1 3CLpro.
-
(2)
In Fig 1m, the dots (red squares) were accidentally removed from its original location during figure formatting, and the related data analysis is correct. The correct image is as below.
Fig 1m Viral RNA copies and viral titers in lung tissues of each group were determined on day 2 after the SARS-CoV-2 delta variant challenge (**P ≤ 0.01).
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jiang, Z., Feng, B., Zhang, Y. et al. Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment. Sig Transduct Target Ther 8, 407 (2023). https://doi.org/10.1038/s41392-023-01665-4
Published:
Version of record:
DOI: https://doi.org/10.1038/s41392-023-01665-4
